We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Kaiser Aluminum
KALU
$3.03B
| $845K | ﹤0.01% |
+7,009
| New | +$887K |
|
1752
Amalgamated Financial
AMAL
$1.52B
| $843K | ﹤0.01% |
+21,680
| New | +$822K |
|
1753
Monro
MNRO
$361M
| $841K | ﹤0.01% |
+52,458
| New | +$1.02M |
|
1754
Benchmark Electronics
BHE
$3.02B
| $836K | ﹤0.01% |
+14,921
| New | +$803K |
|
1755
Immunovant
IMVT
$9.03B
| $835K | ﹤0.01% |
+33,623
| New | +$870K |
|
1756
Huron Consulting
HURN
$2.36B
| $835K | ﹤0.01% |
+6,550
| New | +$985K |
|
1757
Park Hotels & Resorts
PK
$3.02B
| $833K | ﹤0.01% |
+79,128
| New | +$874K |
|
1758
Liberty Global Class A
LBTYA
$3.54B
| $833K | ﹤0.01% |
+68,879
| New | +$802K |
|
1759
Eos Energy Enterprises
EOSE
$1.43B
| $828K | ﹤0.01% |
+166,868
| New | +$1.79M |
|
1760
Financial Institutions
FISI
$819M
| $827K | ﹤0.01% |
+26,068
| New | +$839K |
|
1761
MGP Ingredients
MGPI
$383M
| $826K | ﹤0.01% |
+44,939
| New | +$1M |
|
1762
Celldex Therapeutics
CLDX
$3.29B
| $826K | ﹤0.01% |
+26,037
| New | +$710K |
|
1763
Mineralys Therapeutics
MLYS
$2.3B
| $826K | ﹤0.01% |
+30,474
| New | +$894K |
|
1764
Myriad Genetics
MYGN
$292M
| $825K | ﹤0.01% |
+183,368
| New | +$955K |
|
1765
Extreme Networks
EXTR
$3.19B
| $825K | ﹤0.01% |
+54,705
| New | +$816K |
|
1766
Burford Capital
BUR
$938M
| $824K | ﹤0.01% |
+182,214
| New | +$1.59M |
|
1767
HCI Group
HCI
$2.27B
| $818K | ﹤0.01% |
+5,291
| New | +$866K |
|
1768
Loar Holdings
LOAR
$7.29B
| $814K | ﹤0.01% |
+14,215
| New | +$959K |
|
1769
FB Financial Corp
FBK
$3.07B
| $811K | ﹤0.01% |
+15,613
| New | +$878K |
|
1770
Nektar Therapeutics
NKTR
$2.48B
| $810K | ﹤0.01% |
+11,254
| New | +$641K |
|
1771
Sable Offshore Corp
SOC
$771M
| $806K | ﹤0.01% |
+48,790
| New | +$570K |
|
1772
Crane NXT
CXT
$2.9B
| $806K | ﹤0.01% |
+19,849
| New | +$963K |
|
1773
Stewart Information Services
STC
$2.08B
| $805K | ﹤0.01% |
+13,079
| New | +$871K |
|
1774
Veeco
VECO
$3.33B
| $802K | ﹤0.01% |
+23,681
| New | +$755K |
|
1775
Tenable Holdings
TENB
$3.89B
| $800K | ﹤0.01% |
+47,317
| New | +$993K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.